Lung Cancer Clinical Trial
Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2
Summary
The purpose of this noncomparative study is to obtain preliminary estimates of the efficacy of erlotinib and standard chemotherapy in patients with advanced, previously untreated nonsmall cell lung cancer (NSCLC) and an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 2. The study will also evaluate the safety of single-agent erlotinib in this patient population.
Eligibility Criteria
Inclusion Criteria:
Stage IIIB or IV Nonsmall cell lung cancer (NSCLC)
No prior chemotherapy
Eastern Cooperative Oncology Group (ECOG) Performance Status 2
Clinically or radiologically measurable disease per RECIST criteria
Exclusion Criteria:
Gastro-intestinal abnormalities
Any concurrent anticancer therapy
Prior treatment with epidermal growth factor receptor (EGFR) inhibitors of any kind
Other active malignancies
Uncontrolled brain metastases
Severe abnormalities of the cornea
Significant cardiac disease
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 19 Locations for this study
Greenbrae California, 94904, United States
San Diego California, 92123, United States
Fort Lauderdale Florida, 33308, United States
Miami Beach Florida, 33140, United States
Miami Florida, 33136, United States
Evanston Illinois, 60201, United States
Peoria Illinois, 61615, United States
Louisville Kentucky, 40202, United States
Baltimore Maryland, 21237, United States
Reno Nevada, 89502, United States
New York New York, 10021, United States
Bismarck North Dakota, 58503, United States
Canton Ohio, 44718, United States
Cleveland Ohio, 44106, United States
Columbus Ohio, 43210, United States
Philadelphia Pennsylvania, 19107, United States
Charleston South Carolina, 29403, United States
Knoxville Tennessee, 37920, United States
Nashville Tennessee, 37203, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.